NewAmsterdam Pharma Co N.V. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
  • NewAmsterdam Pharma Co N.V. Earnings Per Share, Basic for the quarter ending December 31, 2024 was -0.91 USD/shares, a 51.7% decline year-over-year.
  • NewAmsterdam Pharma Co N.V. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -2.56 USD/shares, a 19.1% decline year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Earnings Per Share, Basic for 2024 was -2.56 USD/shares, a 19.1% decline from 2023.
  • NewAmsterdam Pharma Co N.V. annual Earnings Per Share, Basic for 2023 was -2.15 USD/shares, a 80.7% decline from 2022.
  • NewAmsterdam Pharma Co N.V. annual Earnings Per Share, Basic for 2022 was -1.19 USD/shares, a 68.8% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$3 $0 -19.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$2 -$1 -80.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 -$1 +$2.62 +68.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 -$4 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.